[Federal Register Volume 85, Number 33 (Wednesday, February 19, 2020)]
[Page 9484]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-03177]



Advisory Committee on the Medical Uses of Isotopes: Meeting 

AGENCY: U.S. Nuclear Regulatory Commission.

ACTION: Notice of meeting.


    The U.S. Nuclear Regulatory Commission (NRC) will convene a meeting 
of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on 
March 30-31, 2020. A sample of agenda items to be discussed during the 
public session includes:
    (1) A discussion on medical-related events; (2) a discussion on the 
ACMUI's recommendations regarding the definition of patient 
intervention and other actions exclusive of medical events; (3) a 
discussion on the U.S. Federal Drug Administration's regulatory process 
for drugs and devices; (4) a discussion on the overview of the NRC's 
Nuclear Material Events Database; (5) a discussion on the status of 
emerging and trending radiopharmaceuticals; and (6) a discussion on the 
ACMUI's recommendations on the need for an interventional radiologist 
representative position on the ACMUI.
    The agenda is subject to change. The current agenda and any updates 
will be available at https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2020.html or by emailing Ms. Kellee Jamerson at the 
contact information below.
    Purpose: Discuss issues related to 10 CFR part 35 Medical Use of 
Byproduct Material.
    Date and Time: March 30, 2020 from 8:30 a.m. to 2:45 p.m. and March 
31, 2020 from 8:30 a.m. to 2:00 p.m. Eastern Standard Time.
    Address for Public Meeting: U.S. Nuclear Regulatory Commission, Two 
White Flint North Building, Room T-2D30, 11545 Rockville Pike, 
Rockville, Maryland 20852.
    Public Participation: Any member of the public who wishes to 
participate in the meeting in person or via phone should contact Ms. 
Jamerson using the information below. The meeting will also be webcast 
live from the NRC's Webcast Portal at https://video.nrc.gov/ gov/. Contact 
Information: Ms. Kellee Jamerson, email: [email protected], 
telephone: (301) 415-7408.

Conduct of the Meeting

    Darlene F. Metter, M.D. will chair the meeting. Dr. Metter will 
conduct the meeting in a manner that will facilitate the orderly 
conduct of business. The following procedures apply to public 
participation in the meeting:
    1. Persons who wish to provide a written statement should submit an 
electronic copy to Ms. Jamerson using the contact information listed 
above. All submittals must be received by March 25, 2020, three 
business days before the meeting, and must pertain to the topics on the 
agenda for the meeting.
    2. Questions and comments from members of the public will be 
permitted during the meeting, at the discretion of the ACMUI Chairman.
    3. The draft transcript and meeting summary will be available on 
the ACMUI's website https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2020.html on or about May 12, 2020.
    4. Persons who require special services, such as those for the 
hearing impaired, should notify Ms. Jamerson of their planned 
    This meeting will be held in accordance with the Atomic Energy Act 
of 1954, as amended (primarily Section 161a); the Federal Advisory 
Committee Act (5 U.S.C. App); and the Commission's regulations in title 
10 of the Code of Federal Regulations, Part 7.

    Dated at Rockville, Maryland this 12th day of February, 2020.

    For the U.S. Nuclear Regulatory Commission.
Russell E. Chazell,
Advisory Committee Management Officer.
[FR Doc. 2020-03177 Filed 2-18-20; 8:45 am]